Emmet Fraizer was The Transmitter’s editorial assistant from 2022 to 2024.
Emmet Fraizer
Editorial Assistant
The Transmitter
From this contributor
Into the woods with Susan Masino
When she isn't researching the links between metabolism and brain activity, this neuroscientist logs time in forests and advocates for protecting green spaces.
Neuroscience group to relocate 2025 meeting slated for Florida
Going forward, the American College of Neuropsychopharmacology plans to gather at “non-discriminatory sites,” following the passage of Florida laws targeting LGBTQ+ people and reproductive rights.
Neuroscience group to relocate 2025 meeting slated for Florida
Link between autism and transness being misused, scientists say
Some researchers are pushing back — with mixed results.
Link between autism and transness being misused, scientists say
Autism in Adulthood gets its first impact factor
The 4-year-old journal focuses on research that aims to improve the lives of autistic adults.
Autism in Adulthood gets its first impact factor
New estimate suggests most autistic adults in England lack a formal diagnosis
The finding underscores a need for adult autism diagnostic services.
New estimate suggests most autistic adults in England lack a formal diagnosis
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.